GNS Hosts Webinar Discussing Causal AI for Inferring Patient Response

by Simona Gilman | Nov 15, 2019 | Events, Featured Posts

On November 12 GNS Healthcare scientists were joined by Dr. Alan Venook of UCLA and the Alliance for Clinical Trials in Oncology to discuss understanding what drugs work for whom in the context of colorectal cancer. To view the webinar recording or download the...

Cigna Invests In GNS Healthcare Precision Medicine Venture

by GNS Healthcare | Jul 9, 2019 | Featured Posts, News

Forbes contributor Bruce Japsen notes that the Cigna investment “fits the effort by health insurance companies to use claims data and related patient health information to better target illness and provide more cost-effective and high quality patient care. These...

GNS Healthcare Raises $23 Million Led by Cigna Ventures

by GNS Healthcare | Jul 9, 2019 | Featured Posts, Press Releases

Cigna Ventures taps GNS’ technology and solutions to further advance whole person health for Cigna’s customers and clients Additional partners participating in recent funding round include Amgen Ventures, Celgene Corporation, Echo Health Ventures and Alexandria...

GNS Among Ways Amgen is Applying AI to Combat Serious Illness

by GNS Healthcare | Jul 8, 2019 | Featured Posts, News

Wired magazine dove in to a few approaches Amgen is taking to using AI to combat serious illness and one of those ways is by partnering with GNS! Amgen, the world’s largest independent biotech company, is leading the charge in combining life sciences with data...

Colin Hill Discusses AI and Machine Learning in Cancer Medicine at The Hill’s Future of Healthcare Summit

by GNS Healthcare | Jun 26, 2019 | Events, Featured Posts

Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at The Hill’s inaugural Future of Healthcare Summit to discuss the impact of technology on the transformation of care. Panelists included: Justin Barad, Co-Founder and CEO, Osso VR...